A
AstraZeneca
What Science Can Do
Cambridge, UK (US: Gaithersburg, MD)
90,000+
About AstraZeneca
Industry:
Pharmaceuticals
Founded:
1999
Founders:
Merger of Astra AB and Zeneca
Status:
Public (NASDAQ: AZN)
Funding & Growth
Total Raised:
N/A
Valuation:
$220B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Strong oncology pipeline
- • Growing presence in US (Gaithersburg, Boston)
- • Investment in AI/ML
- • Diverse therapeutic areas
- • Good benefits
✗ Cons
- • UK headquarters (timezone)
- • Large company bureaucracy
- • Some integration challenges
- • Geographic spread of teams